Monday, June 28, 2021 3:34:22 PM
THE INEPT DECISIONS TO GIVE VACCINES THAT KILL AND INJURE STILL CONTINUE IN THE US WHILE THE RLFTF / NRXP IS WAITING ON APPROVAL BY SLOW AS MOLASSES ( OR INEPT ) POWERS THAT BE.
BELOW IS SOMETHING FOR ANY NUT CASE TO FACT CHECK !!!!!!!!!!
https://www.zerohedge.com/covid-19/world-health-organization-says-do-not-give-children-experimental-coronavirus-vaccine-shots
"In America, national, state, and local governments are pulling out all the stops to advance giving experimental coronavirus shots to children down to the age of 12." .....crazy........kind of like letting criminal illegal aliens out of jail that have committed murder
AVIPTADIL AND ZYESAMI ARE SAFE AND EFFECTIVE AND PATIENTLY WAITING FOR APPROVAL
BELOW IS SOMETHING FOR ANY NUT CASE TO FACT CHECK !!!!!!!!!!
https://www.zerohedge.com/covid-19/world-health-organization-says-do-not-give-children-experimental-coronavirus-vaccine-shots
"In America, national, state, and local governments are pulling out all the stops to advance giving experimental coronavirus shots to children down to the age of 12." .....crazy........kind of like letting criminal illegal aliens out of jail that have committed murder
AVIPTADIL AND ZYESAMI ARE SAFE AND EFFECTIVE AND PATIENTLY WAITING FOR APPROVAL
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
